Next Article in Journal
Clinical Outcomes in a Large Canadian Centralized CLL Clinic Based on Treatment and Molecular Factors over a Decade
Next Article in Special Issue
Prospective Clinical Trials to Advance the Study of Immune Checkpoint Inhibitor Toxicity
Previous Article in Journal
Radiotherapy in Uveal Melanoma: A Review of Ocular Complications
Previous Article in Special Issue
Sustained Improvement in the Management of Patients with Non-Small-Cell Lung Cancer (NSCLC) Harboring ALK Translocation: Where Are We Running?
 
 
Article

Article Versions Notes

Curr. Oncol. 2023, 30(7), 6397-6410; https://doi.org/10.3390/curroncol30070471
Action Date Notes Link
article xml file uploaded 5 July 2023 06:06 CEST Original file -
article xml uploaded. 5 July 2023 06:06 CEST Update -
article pdf uploaded. 5 July 2023 06:06 CEST Version of Record -
article supplementary file uploaded. 5 July 2023 06:06 CEST - https://www.mdpi.com/1718-7729/30/7/471#supplementary
article html file updated 5 July 2023 06:07 CEST Original file -
article html file updated 5 July 2023 06:08 CEST Update -
article html file updated 5 July 2023 06:10 CEST Update -
article xml file uploaded 5 July 2023 06:33 CEST Update -
article xml uploaded. 5 July 2023 06:33 CEST Update https://www.mdpi.com/1718-7729/30/7/471/xml
article pdf uploaded. 5 July 2023 06:33 CEST Updated version of record https://www.mdpi.com/1718-7729/30/7/471/pdf
article html file updated 5 July 2023 06:35 CEST Update -
article html file updated 20 July 2023 20:34 CEST Update https://www.mdpi.com/1718-7729/30/7/471/html
Back to TopTop